Market Snapshot
S&P Futures
3,779.5
Dow Futures
30,569
Nasdaq Futures
11,622.75
Aclarion, Inc. (ACON) stock declined over -3.75% intraday to trade at $0.89 a share on NASDAQ. The stock opened with a gain of 8.54% at $0.92 and touched an intraday high of $0.93, falling -2.63% against the last close of $0.914. The stock went to a low of $0.86 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-07-01 | $0.92 | $0.93 | $0.86 | $0.92 | 40,300 |
2022-06-30 | $0.82 | $1.03 | $0.8 | $0.914 | 476,700 |
2022-06-29 | $0.935 | $0.935 | $0.85 | $0.861 | 16,600 |
2022-06-28 | $0.945 | $0.945 | $0.84 | $0.88 | 35,900 |
2022-06-27 | $0.924 | $0.924 | $0.87 | $0.883 | 15,000 |
2022-06-24 | $0.88 | $0.96 | $0.88 | $0.9 | 31,200 |
2022-06-23 | $0.84 | $0.935 | $0.84 | $0.885 | 80,700 |
2022-06-22 | $0.99 | $1.1 | $0.81 | $0.835 | 281,500 |
2022-06-21 | $0.918 | $0.943 | $0.783 | $0.814 | 90,900 |
2022-06-17 | $1 | $1.04 | $0.88 | $0.88 | 63,300 |
Employees-
Beta-
Sales or Revenue60.29 Thousands
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryHealth Care Technology
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Aclarion, Inc. (NASDAQ: ACON) stock price is $0.89 as of the last check on Friday, July 1. During the trading session, ACON stock reached the peak price of $0.93 while $0.86 was the lowest point it dropped to.
The NASDAQ listed ACON is part of Health Care Technology industry that operates in the broader Health Care sector. Aclarion, Inc. , a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States.
Dr. Jeffrey John Thramann M.D.
Exec. Chairman
Mr. Brent Ness
CEO, Pres & Director
Mr. John Lorbiecki
Chief Financial Officer
Mr. Ryan Bond
Chief Strategy Officer
ACON stock traded closed the last session at $0.92, which is $-0.03 or -3.75% lower than its previous close of $0.914. ACON's current trading price is 13.16% lower than its 52-week high of $4.05 where as its distance from 52-week low of 0.78% is -78.14%.
Number of ACON employees currently stands at -. ACON operates from 951 Mariners Island Boulevard, Suite 300, San Mateo, CA 94404, United States.
Official Webiste of $ACON is: https://www.aclarion.com
ACON could be contacted at ACON operates from 951 Mariners Island Boulevard, Suite 300, San Mateo, CA 94404, United States, or at phone #650-241-1741 and can also be accessed through its website.
ACON stock volume for the day was 86,183 shares while in the previous session number of ACON shares traded was 40,300 . The average number of ACON shares traded daily for last 3 months was 1.33 Million.
The percentage change in ACON stock occurred in the recent session was -3.75% while the dollar amount for the price change in ACON stock was $-0.03.
In the recent session, the day high for ACON stock was $0.93 while the low for ACON stock touched on the day was $0.86.
The market value of ACON currently stands at 6.84 Million with its latest stock price at $0.89 and 7.72 Million of its shares outstanding.